Letter in Support of FDA Enforcement of Compounding Law

Letter in Support of FDA Enforcement of Compounding Law

On November 20, The Pew Charitable Trusts—joined by the American Public Health Association, the Biotechnology Industry Organization, the Generic Pharmaceutical Association, the Pharmaceutical Research and Manufacturers of America, and Trust for America’s Health—sent a letter to the Food and Drug Administration (FDA) supporting their enforcement of federal law on drug compounding. 

Contaminated compounded steroid injections from a single pharmacy in Massachusetts in 2012 and 2013 were associated with 751 illnesses and 64 deaths across multiple states. Federal law, as updated by the Drug Quality and Security Act of 2013,  will help prevent a repeat of this tragedy, but only if FDA is free to proactively enforce against illegal compounding activity.

Download the Letter (PDF)

America’s Overdose Crisis
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Quick View

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.